禽流感病毒介绍
人畜共患传染病-禽流感

人畜共患传染病-禽流感
禽流感,也称为禽流行性感冒,是由甲型流感病毒引起的一种急性传染病,属于人畜共患病的一种。
它主要发生在禽类,如鸡、鸭、鹅、鸽子等,但也可感染人类,称为“人禽流感病”。
禽流感病毒根据其致病性的大小,分为高致病性、低致病性和无致病性三种,其中高致病性禽流感传播快、病情重、病死率很高,对人类和家禽养殖业都构成了严重威胁。
禽流感的传播途径主要包括呼吸道传播和接触传播。
呼吸道传播是指病毒通过患者的鼻腔、气道等相互传播,如打喷嚏时可能导致病毒在空间内扩散,其他人群在这个空间内呼吸时容易被感染。
接触传播则是指患者接触被禽流感病毒感染的禽类或其分泌物、排泄物后,如果未及时清洗双手,再触摸自己或他人的眼部、口部、鼻部等,就容易导致病毒感染。
为了预防禽流感,我们需要采取一系列有效的措施。
首先,要远离传染源,避免与禽流感病毒携带者亲密接触,并对家中进行定期消毒,保持空气流通。
其次,要切断传播途径,外出时佩戴口罩和手套,减少在外用餐的次数,如有必要在外用餐,应备好公筷,避免与他人共用餐具。
此外,易感人群还应加强体育锻炼,提高免疫力,养成良好的卫生习惯,勤洗手,并确保食用全熟的禽类和蛋类。
总之,禽流感是一种严重的人畜共患病,对人类和家禽养殖业都构成了巨大威胁。
因此,我们需要高度重视禽流感的预防工作,采取有效措施切断其传播途径,保护自己和家人的健康。
禽流感病毒的免疫研究进展

禽流感病毒的免疫研究进展禽流感是由禽流感病毒(avian influenza virus)引起的家禽呼吸系统疾病,主要感染家禽,如鸡、鸭、鹅等,但极少数情况下也可以传染给人类。
自从2003年中国发生了SARS疫情以来,禽流感疫情就被公众所关注。
禽流感的爆发不仅对家禽养殖业产生了巨大的经济影响,更是对人类健康造成了巨大的威胁。
因此,对禽流感的病毒学特性和免疫学研究已经成为了当前研究的热点之一。
禽流感病毒的病理学特性禽流感病毒是一种RNA病毒,属于正反式病毒科(Orthomyxoviridae),分为A、B、C、D四种型号。
其中只有A型和B型病毒会引起流感病毒,而D型病毒则主要感染牲畜。
A型病毒具有高变异率和广泛感染性,可以感染多种动物和人类。
据统计,自2003年开始,全球已经发生了多次禽流感大规模暴发,间歇性地在全球不同地区爆发。
1.清洁蛋白材料。
禽流感病毒外表皮有两种糖蛋白质:血凝素和神经氨酸酯化酶。
其中血凝素是禽流感病毒的主要清洁标记物,其血凝素亚型不同决定了其毒性和致病性的差异。
2.覆盖膜。
每个病毒都包含了一层薄膜,这是由病毒在宿主细胞内复制过程中夺取细胞膜形成的。
病毒的薄膜的主要成分是磷脂类物质和覆盖蛋白质。
3.病毒复制能力。
禽流感病毒具有强大的复制能力和变异能力,可以在任何宿主内复制。
病毒的感染和复制也受到宿主细胞的限制,禽流感病毒能感染和复制于多种宿主细胞中,然而只在特定环境下才会产生足够的病毒产生细胞,从而继续传播病毒。
禽流感病毒的病原学特性决定了其研究的重要性,研究其免疫学特性则是控制禽流感疫情的重要途径之一。
禽流感病毒的免疫学特性主要涉及以下几个方面。
1.病毒抗原结构分析。
研究禽流感病毒血凝素、内质膜蛋白、核蛋白、非结构蛋白等多种蛋白结构,寻找高度保守的免疫原性表位,为开发新型疫苗提供理论依据。
2.疫苗研发。
目前,研究禽流感病毒免疫学特性主要集中在疫苗的研制上。
禽流感病毒的血凝素亚型具有多样性,不同亚型的血凝素互相之间没有交叉保护能力。
禽流感特点及防控措施

禽流感特点及防控措施禽流感是一种由禽类病毒引起的疾病,可造成鸡、鸭、鹅等家禽的严重危害。
禽流感病毒具有高度突变性,能够在不同的宿主中发生变异,且具有强烈的传染性和致死性。
禽流感的主要特点及防控措施如下:一、病原特点1.强传染性:禽流感病毒具有极强的传染性,可以通过直接接触、气溶胶传播、被污染的空气、饮水和食物等途径传播,病毒具有很强的进攻性和适应性,传染能力极强。
2.高致病性:禽流感病毒具有高致病性,易造成家禽严重的呼吸道症状和腹泻,甚至出现瘫痪和死亡等严重后果,其中H5N1亚型病毒的致病率超过了70%。
3.病变广泛:禽流感病毒可引起呼吸道和消化道等系统的病变,导致吞咽困难、呼吸急促、呕吐腹泻、羽毛脱落等严重症状,且病变范围广,病程长,并且对主要宿主的屠宰和处理等步骤有很大影响。
二、防控措施1.加强卫生防控:加强家禽场、交易市场、公共场所等环境和设施的清洁和消毒工作,强化投喂、饮水和操作人员的卫生管理,尤其是要加强对野生鸟类等野生动物的管控和监测工作,做好病毒监测、预警和防控工作。
2.加强病原监测:建立病毒监测平台,定期监测主要宿主的感染情况和病毒分布情况,密切监测疫情,及时发现、报告和控制疫情,对发现病例的家禽数量进行紧急控制,减少病毒的传播和扩散。
3.控制和消灭感染源头:从源头控制和消灭感染病毒的家禽数,采取隔离治疗、宰杀和无害化处理等措施,切断疫源传播链,防止疫情扩大,并做好宰杀和无害化处理等工作,防止病毒污染土壤和水源等环境。
4.强化预防和控制措施:积极宣传和推广禽流感预防知识,提高公众的预防意识和自我防护能力,加强农业行业监管和农业生产安全生产,确保环境安全和禽类产品安全。
5.处理病死禽畜:对病死家禽和家畜,应按照相关法律法规进行无害化处理,避免病毒扩散和污染环境。
2024年人感染高致病性禽流感防治知识(三篇)

2024年人感染高致病性禽流感防治知识一、什么是禽流感?禽流感是禽流行性感冒的简称, 是由甲型流感病毒引起的禽类传染性疾病, 容易在鸟类(尤其是鸡)之间引起流行, 过去在民间称作鸡瘟。
禽类感染后死亡率很高。
二、什么是人感染高致病性禽流感?禽流感病毒可分为高致病性、低致病性和非致病性三大类。
其中高致病性禽流感是由H5和H7亚毒株(以H5N1和H7N7为代表)引起的疾病。
高致病性禽流感因其在禽类中传播快、危害大、病死率高, 被世界动物卫生组织列为A类动物疫病, 我国将其列为一类动物疫病。
高致病性禽流感H5N1是不断进化的, 其寄生的动物(又叫宿主)范围会不断扩大, 可感染虎、家猫等哺乳动物, 正常家鸭携带并排出病毒的比例增加, 尤其是在猪体内更常被检出。
高致病性禽流感病毒可以直接感染人类。
xx年, 在我国的香港地区, 高致病性禽流感病毒H5N1型导致了18人感染, 6人死亡, 首次证实高致病性禽流感可以危及人的生命。
截止到xx年11月为止, 发现H5N1病毒的流行地区有:柬埔寨、中国内地、台湾、香港、印尼、日本、老挝、马来西亚、韩国、泰国、越南、蒙古、俄罗斯、哈萨克斯坦、土耳其、罗马尼亚、希腊等国。
人感染高致病性禽流感是《传染病防治法》中规定的按甲类传染病采取预防、控制措施的乙类传染病。
三、人是怎样感染上禽流感的?禽流感病毒可通过消化道和呼吸道进入人体传染给人, 人类直接接触受禽流感病毒感染的家禽及其粪便或直接接触禽流感病毒也可以被感染。
通过飞沫及接触呼吸道分泌物也是传播途径。
如果直接接触带有相当数量病毒的物品, 如家禽的粪便、羽毛、呼吸道分泌物、血液等, 也可经过眼结膜和破损皮肤引起感染。
四、人感染高致病性禽流感患者有哪些表现?人类患上人感染高致病性禽流感后, 起病很急, 早期表现类似普通型流感。
主要表现为发热, 体温大多在39℃以上, 持续1~7天, 一般为3~4天, 可伴有流涕、鼻塞、咳嗽、咽痛、头痛、全身不适, 部分患者可有恶心、腹痛、腹泻、稀水样便等消化道症状。
禽流感生物学特征

禽流感生物学特征
禽流感,也被称为鸟流感,是由禽流感病毒引起的一种动物传染病。
以下是禽流感病毒的一些生物学特征:
1. 病原体:
病毒类型:禽流感病毒主要属于A型流感病毒,其中H5、H7、H9是与家禽相关的亚型。
2. 抗原变异性:
抗原演变:禽流感病毒的表面糖蛋白(血凝素和神经氨酸酶)容易发生抗原演变,使得人类和动物难以对抗不断变异的病毒。
3. 宿主范围:
禽类:禽流感病毒的天然宿主包括家禽,如鸡、鸭、鹅等。
哺乳动物:在某些情况下,禽流感病毒也可能传播给哺乳动物,包括人类。
4. 传播途径:
飞沫传播:通过飞沫传播是主要的传播途径,禽类之间通过飞沫传播是常见的感染方式。
直接接触:直接接触感染源、污染物或患病的动物也是一种传播途径。
5. 致病性:
变异性致病性:不同亚型的禽流感病毒对鸟类和人类的致病性有所不同,某些亚型可能导致高致病性禽流感(HPAI)。
6. 潜伏期:
潜伏期短:禽流感病毒通常具有较短的潜伏期,病情发展较快。
7. 症状:
鸟类症状:在家禽中,症状包括呼吸道症状、神经系统症状,可能导致高死亡率。
人类症状:人类感染禽流感病毒的症状可变,从轻微的呼吸道症状到重症甚至死亡。
8. 预防和控制:
疫苗研发:针对不同亚型的禽流感病毒进行疫苗研发是预防和控制的主要手段。
动物卫生措施:通过动物卫生措施,如隔离、检疫、清洁消毒,防止病毒传播。
了解禽流感病毒的生物学特征对于预防和控制其传播至关重要,尤其是在农业和公共卫生领域。
随着禽流感病毒的不断变异,对其进行监测和研究变得尤为重要。
n7h9禽流感

n7h9禽流感N7H9禽流感导言禽流感是一种由禽类传播到人类的高度传染性疾病,目前已知的禽流感病毒有多种类型,其中N7H9禽流感病毒是最近几年较为关注的一个变异病毒。
本文将就N7H9禽流感的病原特征、传播途径、症状和预防措施进行详细介绍。
一、N7H9禽流感的病原特征1. 病毒类型:N7H9禽流感病毒属于单一肺炎病毒科,亚型为H9N7。
2. 病毒来源:N7H9禽流感病毒主要来自于家禽,如鸭、鹅和鸽子等。
这些禽类的唾液、鼻液、粪便和羽毛等都可能携带病毒。
3. 变异性:N7H9禽流感病毒具有较强的变异能力,可能通过基因突变或重排形成新的亚型。
二、N7H9禽流感的传播途径1. 直接接触:与感染禽类接触,特别是与感染禽类的分泌物、排泄物或血液直接接触,易被感染。
2. 空气传播:感染禽类呼出的气溶胶中的病毒,通过进入呼吸道而导致感染。
这种传播途径的风险主要存在于密集养殖场或市场等人畜混居的场所。
3. 食物传播:食用感染禽流感病毒的家禽或其制品,也可能导致感染。
三、N7H9禽流感的症状1. 病毒潜伏期:感染后,通常在2-10天内出现明显症状。
2. 上呼吸道症状:包括咳嗽、喷嚏、鼻塞等。
3. 发热:感染者出现高热,体温可达到39-40摄氏度。
4. 全身乏力:感染者常感到疲倦、虚弱和没有力气。
5. 呼吸困难:病情严重时,可能导致呼吸系统症状加重,出现呼吸困难。
四、N7H9禽流感的预防措施1. 保持良好的个人卫生习惯:勤洗手,避免用手触摸眼睛、鼻子和嘴巴等面部部位。
2. 避免接触禽类:减少接触家禽、鸟类,尤其是生病或死亡的禽类。
3. 生食禽肉的处理:彻底煮熟禽肉和禽蛋,确保食物安全。
4. 注意保持室内空气流通:保持室内空气流通,减少感染风险。
5. 接种疫苗:相关疫苗对于预防禽流感具有一定效果,可考虑接种。
结语N7H9禽流感是一种具有较强传染性的疾病,对人类健康构成了一定的威胁。
通过了解其病原特征、传播途径、症状和预防措施,我们可以更好地预防和控制其传播。
禽流感病毒的致病机理和免疫防治研究

禽流感病毒的致病机理和免疫防治研究禽流感是一种由禽流感病毒引起的传染病,病毒具有强传染性和致死性,对鸭、鹅、鸡等禽类产生重大威胁。
该病毒在全球范围内广泛存在,尤其是亚洲地区。
近年来,随着经济全球化和人口流动的增加,该病毒引起的疫情不断发生,对禽类养殖产业和人类健康带来了严重影响。
致病机理:禽流感病毒主要通过飞沫传播和接触传播传播。
人体或禽类将病毒摄入后,病毒会首先侵入呼吸道上皮细胞。
在这里,它繁殖并造成细胞受损。
随着病毒的快速繁殖,细胞死亡,可导致肺部炎症、呼吸道症状和胸痛。
病毒还可以入侵消化道和神经系统,导致恶心、呕吐、腹泻、头痛和痉挛。
禽流感病毒能够致病的主要原因是病毒的抗原力和攻击力。
抗原力指的是病毒的抵御能力,攻击力指的是病毒对宿主细胞的感染能力。
禽流感病毒的攻击力非常强,能够迅速感染并破坏宿主细胞,甚至在很短的时间内繁殖数十亿个病毒。
另外,禽流感病毒还具有高度变异性。
由于病毒基因的不断变异,导致抗体不能有效地中和病毒,使得该病毒逐渐产生多种亚型和血清型。
这种高度变异性也给疫苗研制和免疫防治工作带来了极大挑战。
免疫防治:禽流感病毒的防治主要采用疫苗和药物的方式进行。
目前,已有多种疫苗用于禽类免疫,如H5N1疫苗和H7N9疫苗。
然而,由于病毒的变异性,已有的疫苗可能无法对新亚型病毒产生完全的保护,因此需要开发新型疫苗。
此外,药物也是一种有效的防治手段。
目前,针对禽流感病毒的治疗药物主要包括中和病毒的抗体、抗病毒药物和免疫调节剂。
但是,由于该病毒的高度变异性,疗效可能会受到一定影响。
除此之外,对于禽流感病毒的预防还需要采取一系列措施。
禽类饲养场应该建立科学的消毒措施,确保饲养环境的卫生洁净;同时,对于散养禽类,要加强对禽类环境的管理和卫生防护工作,降低感染的风险。
总的来说,禽流感病毒的致病机理和防治措施研究仍需加强。
未来,随着科技的不断发展和创新,或许会有更加有效的免疫防治方法被引入,为禽类养殖产业的发展提供全方位支持。
高致病性禽流感病毒感染的科普知识课件

谢谢观看
旅行时
前往禽流感疫情高发地区时,应采取必要的防护 措施。
避免与禽类接触,注意个人卫生。
何时需要警惕高致病性禽流感?
季节性变化
在冬春季节,禽流感病毒活动较为频繁,需加强 监测。
此时野生鸟类迁徙,可能增加传播风险。
如何预防高致病性禽流感病 毒感染?
如何预防高致病性禽流感病毒感染?
个人防护
与禽类接触时,应佩戴防护装备并保良好的手 卫生。
定义
高致病性禽流感病毒是一种影响鸟类的病毒,尤 其是家禽,能够引起严重的疾病和高死亡率。
HPAI由H5和H7亚型的流感病毒引起,具有高度传 染性。
什么是高致病性禽流感病毒(HPAI)?
传播途径
该病毒主要通过直接接触感染的禽类、污染的环 境或食物传播。
野鸟是HPAI的主要宿主,能够在不显现症状的情 况下传播病毒。
谁会受到影响?
生态系统
野生鸟类和生态系统也会受到影响,特别是那些 与家禽有交互的物种。
生态链的变化可能导致其他物种的生存受到威胁 。
何时需要警惕高致病性禽流 感?
何时需要警惕高致病性禽流感?
疫情爆发时
当地禽类或野生鸟类中出现HPAI疫情时,应提高 警惕。
应及时关注官方的疫情通报和健康建议。
何时需要警惕高致病性禽流感?
什么是高致病性禽流感病毒(HPAI)?
症状
感染HPAI的禽类可能出现呼吸道症状、神经症状 、消化道症状以及迅速死亡等。
人类感染后可能出现流感样症状,严重者可导致 肺炎或其他并发症。
为什么高致病性禽流感病毒 引起关注?
为什么高致病性禽流感病毒引起关注?
公共卫生风险
HPAI不仅影响家禽业,还可能对人类健康构成威 胁,尤其是在病毒变异后。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
January 10, 2006 Page 1 of 3KEY FACTSInformation about Avian Influenza (Bird Flu) and Avian Influenza A (H5N1) VirusThis fact sheet provides general information about bird flu and information about one type of bird flu, called avian influenza A (H5N1) that is infecting birds in Asia and has infected some humans. Also see the Frequently Asked Questions (FAQs) (http://www.who.int/csr/disease/avian_influenza/avian_faqs/en/index.html ) on the World Health Organization (WHO) website.Avian Influenza (Bird Flu)Avian influenza in birdsAvian influenza is an infection caused by avian (bird) influenza (flu) viruses. These influenza viruses occur naturally among birds. Wild birds worldwide carry the viruses in their intestines, but usually do not get sick from them. However, avian influenza is very contagious among birds and can make somedomesticated birds, including chickens, ducks, and turkeys, very sick and kill them.Infected birds shed influenza virus in their saliva, nasal secretions, and feces. Susceptible birds become infected when they have contact with contaminated secretions or excretions or with surfaces that are contaminated with secretions or excretions from infected birds. Domesticated birds may become infected with avian influenza virus through direct contact with infected waterfowl or other infected poultry, orthrough contact with surfaces (such as dirt or cages) or materials (such as water or feed) that have been contaminated with the virus.Infection with avian influenza viruses in domestic poultry causes two main forms of disease that are distinguished by low and high extremes of virulence. The “low pathogenic” form may go undetected and usually causes only mild symptoms (such as ruffled feathers and a drop in egg production). However, the highly pathogenic form spreads more rapidly through flocks of poultry. This form may cause disease that affects multiple internal organs and has a mortality rate that can reach 90-100% often within 48 hours. Human infection with avian influenza viruses There are many different subtypes of type A influenza viruses. These subtypes differ because of changes in certain proteins on the surface of the influenza A virus (hemagglutinin [HA] and neuraminidase [NA] proteins). There are 16 known HA subtypes and 9 known NA subtypes of influenza A viruses. Many different combinations of HA and NA proteins are possible. Each combination represents a different subtype. All known subtypes of influenza A viruses can be found in birds.Usually, “avian influenza virus” refers to influenza A viruses found chiefly in birds, but infections with these viruses can occur in humans. The risk from avian influenza is generally low to most people, because the viruses do not usually infect humans. However, confirmed cases of human infection from several subtypes of avian influenza infection have been reported since 1997. Most cases of avian influenzainfection in humans have resulted from contact with infected poultry (e.g., domesticated chicken, ducks, and turkeys) or surfaces contaminated with secretion/excretions from infected birds. The spread of avianinfluenza viruses from one ill person to another has been reported very rarely, and transmission has not been observed to continue beyond one person.“Human influenza virus” usually refers to those subtypes that spread widely among humans. There are only three known A subtypes of influenza viruses (H1N1, H1N2, and H3N2) currently circulating among humans. It is likely that some genetic parts of current human influenza A viruses came from birds originally. Influenza A viruses are constantly changing, and they might adapt over time to infect and spread among humans.During an outbreak of avian influenza among poultry, there is a possible risk to people who have contact with infected birds or surfaces that have been contaminated with secretions or excretions from infected birds.Symptoms of avian influenza in humans have ranged from typical human influenza-like symptoms (e.g., fever, cough, sore throat, and muscle aches) to eye infections, pneumonia, severe respiratory diseases (such as acute respiratory distress), and other severe and life-threatening complications. The symptomsof avian influenza may depend on which virus caused the infection.Studies done in laboratories suggest that some of the prescription medicines approved in the United States for human influenza viruses should work in treating avian influenza infection in humans. However, influenza viruses can become resistant to these drugs, so these medications may not always work. Additional studies are needed to demonstrate the effectiveness of these medicines.Avian Influenza A (H5N1)Avian influenza A (H5N1) in Asia and EuropeInfluenza A (H5N1) virus – also called “H5N1 virus” – is an influenza A virus subtype that occurs mainly in birds, is highly contagious among birds, and can be deadly to them.Outbreaks of avian influenza H5N1 occurred among poultry in eight countries in Asia (Cambodia, China, Indonesia, Japan, Laos, South Korea, Thailand, and Vietnam) during late 2003 and early 2004. At that time, more than 100 million birds in the affected countries either died from the disease or were killed in order to try to control the outbreaks. By March 2004, the outbreak was reported to be under control. Since late June 2004, however, new outbreaks of influenza H5N1 among poultry were reported by several countries in Asia (Cambodia, China [Tibet], Indonesia, Kazakhstan, Malaysia, Mongolia, Russia [Siberia], Thailand, and Vietnam). It is believed that these outbreaks are ongoing. Influenza H5N1 infection also has been reported among poultry in Turkey Romania, and Ukraine. Outbreaks of influenza H5N1 have been reported among wild migratory birds in China, Croatia, Mongolia, and Romania.As of January 7, 2006, human cases of influenza A (H5N1) infection have been reported in Cambodia, China, Indonesia, Thailand, Vietnam, and most recently, several cases in Turkey. A January 9, 2006 WHO Situation Report describes detection of the H5 subtype of avian influenza virus in samples from an additional 10 people in Turkey. These samples are undergoing further analysis to determine whether they contain the H5N1 strain. For the most current information about avian influenza and cumulative case numbers, see the World Health Organization (WHO) website athttp://www.who.int/csr/disease/avian_influenza/en/.January 10, 2006 Page 2 of 3Human health risks during the H5N1 outbreakH5N1 virus does not usually infect people, but more than 140 human cases have been reported by the World Health Organization since January 2004. Most of these cases have occurred as a result of people having direct or close contact with infected poultry or contaminated surfaces. So far, the spread of H5N1 virus from person-to-person has been rare and has not continued beyond one person.Of the few avian influenza viruses that have crossed the species barrier to infect humans, H5N1 has caused the largest number of detected cases of severe disease and death in humans. In the current outbreaks in Asia and Europe, more than half of those infected with the virus have died. Most cases have occurred in previously healthy children and young adults. However, it is possible that the only cases currently being reported are those in the most severely ill people, and that the full range of illness caused by the H5N1 virus has not yet been defined.So far, the spread of H5N1 virus from person to person has been limited and has not continued beyond one person. Nonetheless, because all influenza viruses have the ability to change, scientists are concerned that H5N1 virus one day could be able to infect humans and spread easily from one person to another. Because these viruses do not commonly infect humans, there is little or no immune protection against them in the human population. If H5N1 virus were to gain the capacity to spread easily from person to person, an influenza pandemic (worldwide outbreak of disease) could begin. For more information about influenza pandemics, see /flu/pandemic/ and .No one can predict when a pandemic might occur. However, experts from around the world are watching the H5N1 situation in Asia and Europe very closely and are preparing for the possibility that the virus may begin to spread more easily and widely from person to person.Treatment and vaccination for H5N1 virus in humansThe H5N1 virus that has caused human illness and death in Asia is resistant to amantadine and rimantadine, two antiviral medications commonly used for influenza. Two other antiviral medications, oseltamavir and zanamavir, would probably work to treat influenza caused by H5N1 virus, but additional studies still need to be done to demonstrate their effectiveness.There currently is no commercially available vaccine to protect humans against H5N1 virus that is being seen in Asia and Europe. However, vaccine development efforts are taking place. Research studies to test a vaccine to protect humans against H5N1 virus began in April 2005, and a series of clinical trials is under way. For more information about H5N1 vaccine development process, visit the National Institutes of Health website (/news/newsreleases/2005/avianfluvax.htm).For more information, visit /flu,or call CDC at 800-CDC-INFO (English and Spanish) or 888-232-6348 (TTY).January 10, 2006 Page 3 of 3。